MedPath

The effectiveness of de-escalation to cefmetazole for bacteremia. Open-label randomized non-inferiority trial

Not Applicable
Conditions
bacteremia
Registration Number
JPRN-UMIN000028155
Lead Sponsor
Kobe University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
184
Inclusion Criteria

Not provided

Exclusion Criteria

When the patient or the physician treating did not consent to the study participation. Those who had or are likely to have significant past history of cefmetazole side effects, such as anaphylaxis by beta-lactams.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath